January 30, 2023
Walgreens will pay $7 million to the federal government and the state of Tennessee to resolve allegations the pharmacy giant was falsely certifying beneficiaries' compliance with the state's health care program's reauthorization requirements for hepatitis C drugs, the U.S. Department of Justice said Friday.